Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor...

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas with poor prognosis.
• MPNSTs arise sporadically or in individuals with neurofibromatosis type 1 (NF1).
• Loss of CDKN2A/B is a known early event, but its complete inactivation is not always observed, suggesting alternative MPNST initiation pathways.

Purpose of the Study:

• To conduct a comprehensive genomic analysis of MPNST cell lines and tumors.
• To investigate the status of CDKN2A inactivation in MPNST.
• To determine if a single molecular pathway underlies MPNST initiation.

Main Methods:

• Comprehensive genomic analysis of MPNST cell lines and primary tumors.
• Analysis of CDKN2A deletions and point mutations.
• Identification and validation of chromosomal translocations involving CDKN2A using PCR and Sanger sequencing.

Main Results:

• A high frequency of chromosomal translocations involving CDKN2A was identified in MPNST cell lines and tumors.
• Translocation breakpoints frequently clustered in a specific intronic hotspot region near CDKN2A exon 2.
• Bi-allelic inactivation of CDKN2A was confirmed in all analyzed MPNST samples (15 tumors, 8 cell lines).

Conclusions:

• The findings support a single, consistent molecular pathway for MPNST initiation, involving bi-allelic CDKN2A inactivation.
• This unified pathway applies to both sporadic and NF1-related MPNSTs.
• Understanding CDKN2A inactivation mechanisms has significant implications for MPNST diagnostics and therapeutic strategies.